In this study, we have evaluated immune cell infiltration in a syngeneic mouse model using the transplantation of 3LL lung cancer-derived cells with either NRF2 hyperactivation via Keap1 gene deletion or concomitant Keap1-Nrf2 gene deletion. The gene discussed is KEAP1; the disease is lung cancer.